Biotickr logobiotickr

Tryp Therapeutics Inc

The TRYPF stock trades on Otc Markets

Company Description

Tryp Therapeutics is leading psychedelic drug development beyond mental health. Tryp Therapeutics focuses on areas of unmet medical need where other treatments have fallen short. Our pharmaceutical focus on psilocybin has the potential to transform the treatment of chronic pain and other indications, and relieve the suffering of millions of patients. Addressing unmet needs with proven potential. Tryp Therapeutics is one of the first players to help realize this promise, leading the next wave of psychedelic drug development that extends beyond mental health.

Drug Pipeline

Source: Tryp Therapeutics Inc - 20220924
Asset
Indication
Phase
TRP-8802
Neuropsychiatric Disorders
Phase 2
 
 
 
 
 
TRP-8803
Neuropsychiatric Disorders
Phase 2
 
 
 
 
 

Conversation

0 following
Messages Image
Log in or sign up to join the conversation.

0 Comments on TRYPF stock

Newest